Search - tctmd.com

Displaying 801 - 817 of 817

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

June 13, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

June 03, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

May 27, 2011

News Conference News

Different Agents Show Potential as Adjuncts to PCI

May 19, 2011

News Conference News

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

May 18, 2011

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

May 12, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

April 21, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

April 20, 2011

News Daily News

Calcium Scanning May Lower CAD Risk at No Extra Cost

March 23, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

February 13, 2011

News Daily News

Registry Study: AMI Patients at Increased Cancer Risk from Low-Dose Radiation

February 10, 2011

News Daily News

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

February 08, 2011

News Daily News

CK-MB More Accurate Than Troponin in Identifying Post-PCI MI

January 30, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

January 25, 2011

News Daily News

Researchers Accurately Predict Who Will Discontinue Clopidogrel

January 09, 2011

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.